Jan 2024
Conyers acted for Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology and aesthetics company focused on women’s health and breast reconstruction, in connection with its private placement of common shares and pre-funded warrants to certain institutional accredited investors.
Pursuant to the securities purchase agreement, Establishment Labs agreed to sell two million common shares or, in lieu of common shares, pre-funded warrants at a price of US$25 per share. The aggregate gross proceeds from the offering before deducting related expenses are expected to be approximately US$50 million.
Counsel Nicholas Kuria of Conyers’ BVI office advised on the transaction, working alongside O’Melveny & Myers LLP, New York.